Yield10 Bioscience Inc expected to post a loss of 65 cents a share - Earnings Preview

Yield10 Bioscience

09/11/2021 03:07

* Yield10 Bioscience Inc  YTEN.OQ   YTEN.O  is expected to show
a rise in quarterly revenue when it reports  results on November
10. 
* The Woburn, Massachusetts-based company is expected to report 
a 1.5% increase in revenue to $207 thousand from $204 thousand a
year ago, according to the mean estimate from 2 analysts, based
on Refinitiv data. 
​* Refinitiv's mean analyst estimate for Yield10 Bioscience Inc
is for a loss of 65 cents per share. For the same quarter last
year, the company reported a loss of 87 cents per share.
* The current average analyst rating on the shares is "buy" and
the breakdown of recommendations is 2 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell." 
* The mean earnings estimate of analysts was unchanged in the
last three months. ​
* Wall Street's median 12-month price target for Yield10
Bioscience Inc is $25​, about 74.8% above​ its last closing
price of $6.30. ​​​
* Previous quarterly performance (using preferred earnings
measure in US dollars). ​
 QUARTER       STARMINE    REFINITIV  ACTUAL    BEAT,   SURPRI
 ENDING        SMARTESTIM  IBES                 MET,    SE %
               ATE®        ESTIMATE             MISSED  
 Jun. 30 2021  -0.54       -0.54      -0.64     Missed  -18.5
 Mar. 31 2021  -0.54       -0.55      -0.60     Missed  -8.1
 Dec. 31 2020              -0.70      -0.79     Missed  -13.3​
 Sep. 30 2020  -0.95       -0.94      -0.87     Beat    7.9
 ​​Jun.        -1.30       -1.30      -1.09     Beat    16.2
 30 2020                                                
 Mar. 31 2020  -2.13       -1.97      -2.12     Missed  -7.6​
 Dec. 31 2019  -4.59       -4.00      -0.02     Beat    99.5
 Sep. 30 2019  -6.67       -6.60      -6.40     Beat    3
 This summary was machine generated November 9 at 03:07 GMT.  All
figures in US dollars unless otherwise stated